HemaSphere (Jun 2022)

P676: LOW-DOSE FCR COMPARED TO BR IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 ABERRATIONS: A REAL – WORLD RETROSPECTIVE ANALYSIS BY THE CZECH CLL STUDY GROUP.

  • L. Smolej,
  • Y. Brychtová,
  • E. Cmunt,
  • M. Oršulová,
  • P. Vodárek,
  • M. Dostál,
  • P. Turcsányi,
  • R. Urbanová,
  • A. Panovská,
  • J. Zuchnická,
  • J. Mihályová,
  • D. Lysák,
  • M. Brejcha,
  • H. Móciková,
  • K. Klásková,
  • M. Šimkovič,
  • M. Špaček,
  • M. Doubek

DOI
https://doi.org/10.1097/01.HS9.0000845588.22519.a4
Journal volume & issue
Vol. 6
pp. 574 – 575

Abstract

Read online

No abstracts available.